1. Home
  2. EDUC vs GDTC Comparison

EDUC vs GDTC Comparison

Compare EDUC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

N/A

Current Price

$1.32

Market Cap

10.7M

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.06

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
GDTC
Founded
1965
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
12.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
EDUC
GDTC
Price
$1.32
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.2K
13.0K
Earning Date
01-08-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$34,191,000.00
N/A
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
$2.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.73
52 Week High
$1.84
$3.68

Technical Indicators

Market Signals
Indicator
EDUC
GDTC
Relative Strength Index (RSI) 44.39 50.87
Support Level $1.25 $0.96
Resistance Level $1.35 $1.11
Average True Range (ATR) 0.05 0.06
MACD -0.00 0.00
Stochastic Oscillator 28.00 65.71

Price Performance

Historical Comparison
EDUC
GDTC

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: